*	OR T3 T4
R1	Subsumes Arg1:T2 Arg2:T3	
R2	Has_value Arg1:T7 Arg2:T8	
R3	AND Arg1:T6 Arg2:T7	
R4	Has_temporal Arg1:T6 Arg2:T9	
R5	Has_temporal Arg1:T10 Arg2:T11	
R6	Has_value Arg1:T12 Arg2:T13	
R7	AND Arg1:T10 Arg2:T12	
R8	Has_value Arg1:T14 Arg2:T15	
R9	Has_value Arg1:T16 Arg2:T17	
*	OR T14 T16
*	OR T19 T21 T20
R10	AND Arg1:T19 Arg2:T22	
*	OR T30 T32 T31
R11	Subsumes Arg1:T33 Arg2:T30	
R12	Subsumes Arg1:T36 Arg2:T37	
*	OR T40 T39
R13	AND Arg1:T38 Arg2:T36	
R14	Has_temporal Arg1:T38 Arg2:T40	
R15	Has_qualifier Arg1:T42 Arg2:T43	
*	OR T44 T46 T45 T47
R16	Subsumes Arg1:T42 Arg2:T44	
R17	Has_temporal Arg1:T42 Arg2:T49	
R18	AND Arg1:T51 Arg2:T50	
R19	AND Arg1:T55 Arg2:T56	
R20	AND Arg1:T54 Arg2:T55	
*	OR T52 T54 T53
*	OR T58 T57
R21	Has_qualifier Arg1:T61 Arg2:T62	
*	OR T59 T61
R22	Has_qualifier Arg1:T59 Arg2:T58	
*	OR T65 T64
R23	Has_temporal Arg1:T65 Arg2:T66	
*	OR T69 T68
R24	Has_temporal Arg1:T70 Arg2:T71	
R25	Has_temporal Arg1:T70 Arg2:T69	
T1	Drug 0 10	Amiodarone
T2	Drug 12 42	P-glycoprotein (P-gp) inducers
T3	Drug 50 58	rifampin
T4	Drug 60 75	St. John's wort
T6	Procedure 78 90	Liver biopsy
T7	Measurement 111 121	mHAI stage
T8	Value 122 133	4 or higher
T9	Temporal 94 102	any time
T10	Procedure 147 156	FibroScan
T11	Temporal 157 173	within 12 months
T12	Measurement 188 203	liver stiffness
T13	Value 207 223	=9.5 kilo Pascal
T14	Measurement 228 262	AST to platelet ratio index (APRI)
T15	Value 263 267	=2.0
T16	Measurement 272 290	Fibrosis-4 (FIB-4)
T17	Value 291 296	=3.25
T18	Non-representable 298 393	NOTE: If APRI and FIB-4 are discordant one of the other forms of fibrosis staging must be used.
T19	Condition 401 408	allergy
T20	Condition 409 420	sensitivity
T21	Condition 428 444	hypersensitivity
T22	Drug 448 473	components of study drugs
T24	Condition 497 512	Hemochromatosis
T25	Condition 514 544	Alpha-1 antitrypsin deficiency
T26	Condition 546 562	Wilson's disease
T27	Condition 564 584	Autoimmune hepatitis
T28	Condition 586 609	Alcoholic liver disease
T29	Condition 611 637	Drug-related liver disease
T30	Condition 673 679	stroke
T31	Condition 681 692	head injury
T32	Condition 697 730	developmental learning disability
T33	Condition 646 671	NC confounding conditions
T35	Drug 749 772	anti-inflammatory drugs
T36	Drug 808 828	pegylated interferon
T37	Drug 830 837	PEG-IFN
T38	Procedure 793 802	treatment
T39	Temporal 786 792	recent
T40	Temporal 775 782	Current
T42	Condition 847 874	active inflammatory process
T43	Qualifier 841 846	Other
T44	Condition 876 891	major infection
T45	Condition 893 903	malignancy
T46	Condition 905 925	rheumatoid arthritis
T47	Condition 926 945	autoimmune disorder
T49	Temporal 947 971	within the prior 28 days
T50	Procedure 995 1027	magnetic resonance imaging (MRI)
T51	Condition 974 991	Contraindications
T52	Condition 1030 1048	Bleeding diathesis
T53	Condition 1050 1066	thrombocytopenia
T54	Drug 1078 1092	anticoagulants
T55	Condition 1104 1118	contraindicate
T56	Procedure 1119 1134	lumbar puncture
T57	Temporal 1153 1159	active
T58	Qualifier 1137 1149	Uncontrolled
T59	Condition 1160 1170	depression
T61	Condition 1180 1200	psychiatric disorder
T62	Qualifier 1174 1179	other
T64	Condition 1351 1376	alcohol use or dependence
T65	Condition 1343 1347;1359 1376	drug use or dependence
T66	Temporal 1336 1342	Active
T68	Temporal 1501 1506	acute
T69	Temporal 1491 1497	active
T70	Condition 1507 1545	AIDS-defining opportunistic infections
T71	Temporal 1546 1582	within 12 weeks prior to study entry
